Article | August 16, 2016

Concomitant Medications In Clinical Trials: Why The Stakes Are High

Source: goBalto
Concomitant Medications In Clinical Trials: Why The Stakes Are High

By Craig Morgan NZCS, MBA (Hons), PMP, goBalto, Inc.

Almost every reported concomitant medication has a reason – and many, if not all of these reasons should be reported as adverse events. Concomitant medications (a.k.a., con-meds) are other prescription medications, over-the-counter (OTC) drugs or dietary supplements that a study participant takes in addition to the drug under investigation. Con-meds may be used by study subjects for the same indication as the study or for other indications.